| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0193-953X(05)70361-0 |
| P698 | PubMed publication ID | 9551491 |
| P50 | author | Cynthia Shannon Weickert | Q47451384 |
| P2093 | author name string | Kleinman JE | |
| P2860 | cites work | Functional properties of multiple synaptotagmins in brain | Q28242788 |
| GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls | Q28275258 | ||
| Regional, cellular, and subcellular variations in the distribution of D1 and D5 dopamine receptors in primate brain | Q28276882 | ||
| Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? | Q28279719 | ||
| Elimination of cocaine-induced hyperactivity and dopamine-mediated neurophysiological effects in dopamine D1 receptor mutant mice | Q28591400 | ||
| Deficits in Small Interneurons in Prefrontal and Cingulate Cortices of Schizophrenic and Schizoaffective Patients | Q48633690 | ||
| 18. Evidence against progression of in vivo anatomical abnormalities in schizophrenia | Q48647956 | ||
| Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity | Q48669549 | ||
| Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia | Q48691523 | ||
| Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy | Q48712833 | ||
| Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls | Q48712843 | ||
| Increased [3H]kainic acid binding in the prefrontal cortex in schizophrenia | Q48725807 | ||
| Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon | Q48725856 | ||
| Opposing effects of dopamine D2 receptor stimulation on the spontaneous and the electrically evoked release of [3H]gaba on rat prefrontal cortex slices | Q48825673 | ||
| A postmortem study of frontal cortical dopamine D1 receptors in schizophrenics, psychiatric controls, and normal controls | Q48829862 | ||
| Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging | Q48854560 | ||
| The hippocampus and parahippocampus in schizophrenia, suicide, and control brains | Q48865844 | ||
| Increased brain dopamine and dopamine receptors in schizophrenia. | Q48903689 | ||
| Myelination of cortical-hippocampal relays during late adolescence | Q48932523 | ||
| Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding | Q48939331 | ||
| Correlation of regional cerebral blood flow with performance on neuropsychological tests in schizophrenic patients | Q48941072 | ||
| Serotonergic axons in monkey prefrontal cerebral cortex synapse predominantly on interneurons as demonstrated by serial section electron microscopy | Q49012272 | ||
| Local circuit neurons of the prefrontal cortex in schizophrenia: selective increase in the density of calbindin-immunoreactive neurons. | Q51014945 | ||
| [3H]SCH 23390 labeled D1 dopamine receptors are unchanged in schizophrenia and Parkinson's disease. | Q51823312 | ||
| Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study. | Q52033175 | ||
| Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. | Q52051956 | ||
| Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism. | Q52069743 | ||
| Development of cortical circuitry and cognitive function. | Q52074520 | ||
| Gross and histological criteria for developmental disorders in brains of schizophrenics. | Q52245476 | ||
| Hippocampal pathologic findings in schizophrenia. A morphometric study. | Q52515251 | ||
| Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients. | Q54624708 | ||
| Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients. | Q55056638 | ||
| (3H]MK-801 binding sites in postmortem brain regions of schizophrenic patients | Q57781184 | ||
| 3H-spiperone binding sites in post-mortem brains from schizophrenic patients: Relationship to neuroleptic drug treatment, abnormal movements, and positive symptoms | Q57781187 | ||
| Reduced GABA uptake sites in the temporal lobe in schizophrenia | Q60054596 | ||
| DOPAMINE RECEPTORS AND SCHIZOPHRENIA: DRUG EFFECT OR ILLNESS | Q61714109 | ||
| Aromatic Amino Acids and Modification of Parkinsonism | Q67223978 | ||
| Decreased hippocampal expression of a glutamate receptor gene in schizophrenia | Q68292151 | ||
| Morphometry of the parahippocampal gyrus in schizophrenics and controls. Some anatomical considerations | Q68736197 | ||
| Prenatal developmental disturbances in the limbic allocortex in schizophrenics | Q69518888 | ||
| Reversibility of hemodynamic hypofrontality in schizophrenia | Q69892901 | ||
| The dopaminergic innervation of monkey prefrontal cortex: a tyrosine hydroxylase immunohistochemical study | Q69921164 | ||
| Cerebral blood flow in schizophrenic adolescents | Q69992475 | ||
| No D2 receptor increase in PET study of schizophrenia | Q70033743 | ||
| [3H]muscimol binding sites increased in autopsied brains of chronic schizophrenics | Q70158501 | ||
| Abnormal resting regional cerebral blood flow patterns and their correlates in schizophrenia | Q70390933 | ||
| An experimental study of the ventral striatum of the golden hamster. I. Neuronal connections of the nucleus accumbens | Q71303064 | ||
| Autoradiographic characterization of neurotensin receptors in the entorhinal cortex of schizophrenic patients and control subjects | Q71479819 | ||
| 3H-Flupenthixol binding in post-mortem brains of schizophrenics: evidence for a selective increase in dopamine D2 receptors | Q71564942 | ||
| An in vivo study of the prefrontal cortex of schizophrenic patients at different stages of illness via phosphorus magnetic resonance spectroscopy | Q72181807 | ||
| 31phosphorus magnetic resonance spectroscopy of the frontal and parietal lobes in chronic schizophrenia | Q72422975 | ||
| Dopamine receptors and schizophrenia: drug effect or illness? | Q72434972 | ||
| Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors | Q72734923 | ||
| The neurology of schizophrenia | Q74392964 | ||
| Implications of normal brain development for the pathogenesis of schizophrenia | Q29618740 | ||
| The synaptic vesicle cycle: a cascade of protein-protein interactions | Q29620168 | ||
| Lack of a bimodal distribution of ventricular size in schizophrenia: a Gaussian mixture analysis of 1056 cases and controls | Q33283434 | ||
| Stability of CT scan findings in schizophrenia: results of an 8 year follow-up study | Q33627313 | ||
| Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs | Q34192438 | ||
| Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia | Q34209873 | ||
| Hypofrontality in neuroleptic-naive patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London | Q34245156 | ||
| Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system | Q34248307 | ||
| Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain | Q34363450 | ||
| Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics | Q34559171 | ||
| The problem of the frontal lobe: a reinterpretation | Q34701092 | ||
| Low cerebrospinal fluid glutamate in schizophrenic patients and a new hypothesis on schizophrenia | Q34707093 | ||
| Glutamate receptor dysfunction and schizophrenia | Q34719075 | ||
| D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines | Q35528206 | ||
| Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia | Q35947887 | ||
| Temporal lobe pathology in schizophrenia: a quantitative magnetic resonance imaging study. | Q36418220 | ||
| Absence of activation in frontal structures during psychological testing of chronic schizophrenics | Q37038957 | ||
| Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia | Q37636593 | ||
| Schizophrenia and the frontal lobe | Q38201347 | ||
| Increased dopamine-receptor sensitivity in schizophrenia | Q39498162 | ||
| Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect | Q39628495 | ||
| Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey | Q39680193 | ||
| Synaptic development of the cerebral cortex: implications for learning, memory, and mental illness | Q40556161 | ||
| Working memory dysfunction in schizophrenia | Q40582842 | ||
| Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited | Q40635954 | ||
| Neurobiological investigations in cingulate cortex of schizophrenic brain | Q40777852 | ||
| Rab proteins and the road maps for intracellular transport | Q40780300 | ||
| Regulation of gamma-aminobutyric acid synthesis in the brain | Q40868545 | ||
| Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia | Q41026526 | ||
| Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures | Q41102237 | ||
| Evidence of glutamatergic deficiency in schizophrenia | Q41134039 | ||
| D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride | Q41173321 | ||
| Localization of dopamine D4 receptors in GABAergic neurons of the primate brain | Q41198273 | ||
| Deficit and hemispheric asymmetry of GABA uptake sites in the hippocampus in schizophrenia | Q41199819 | ||
| Limbic pathology in schizophrenia: the entorhinal region--a morphometric study. | Q41395921 | ||
| Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia | Q41482417 | ||
| Synaptic density in human frontal cortex — Developmental changes and effects of aging | Q41485344 | ||
| Elevation of brain neuroleptic/dopamine receptors in schizophrenia | Q41530785 | ||
| Bimodal Distribution of Dopamine Receptor Densities in Brains of Schizophrenics | Q41536508 | ||
| Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenics | Q41581740 | ||
| Regional cerebral blood flow in schizophrenics. Tests using the xenon Xe 133 inhalation method | Q41603778 | ||
| Functional and anatomical aspects of prefrontal pathology in schizophrenia | Q41609625 | ||
| Abnormal excitatory neurotransmitter metabolism in schizophrenic brains | Q41670269 | ||
| Quantitative three-dimensional analysis of the catecholaminergic innervation of identified neurons in the macaque prefrontal cortex | Q42444237 | ||
| A quantitative investigation of hippocampal pyramidal cell size, shape, and variability of orientation in schizophrenia | Q43591026 | ||
| Phencyclidine-induced psychosis | Q43637366 | ||
| Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics | Q44116241 | ||
| Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics | Q44239783 | ||
| Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence | Q44240058 | ||
| Post-mortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics. Initial results from a new brain collection | Q44514127 | ||
| Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. II. Role of neuroleptic treatment, attention, and mental effort | Q44579680 | ||
| Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia | Q44610835 | ||
| Dopamine receptor subtype imbalance in schizophrenia | Q45078544 | ||
| Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem | Q45201703 | ||
| Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases | Q45297058 | ||
| Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder | Q45297275 | ||
| Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia | Q45299102 | ||
| Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. | Q45307345 | ||
| An evaluation of structural and functional prefrontal deficits in schizophrenia: MRI and neuropsychological measures. | Q45978892 | ||
| Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. | Q46022290 | ||
| Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development | Q46108002 | ||
| Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia | Q46659291 | ||
| Differential effects of monocular deprivation on glutamic acid decarboxylase and type II calcium-calmodulin-dependent protein kinase gene expression in the adult monkey visual cortex. | Q46808132 | ||
| Perinatal complications and reduced size of brain limbic structures in familial schizophrenia | Q47186745 | ||
| Stability of ventricular size after the onset of psychosis in schizophrenia | Q47430377 | ||
| Reduced Neuronal Size in Posterior Hippocampus of Schizophrenic Patients | Q47436949 | ||
| Asymmetrical loss of glutamate receptor subtype in left hippocampus in schizophrenia | Q48100128 | ||
| Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood | Q48109108 | ||
| Decreased regional cortical gray matter volume in schizophrenia | Q48109683 | ||
| Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains | Q48166703 | ||
| Hippocampal pyramidal cell orientation in schizophrenia. A controlled neurohistologic study of the Yakovlev collection | Q48173287 | ||
| Post-mortem study of chronic schizophrenic brains | Q48174269 | ||
| White matter reduction in the parahippocampal gyrus of patients with schizophrenia | Q48186204 | ||
| Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography | Q48186320 | ||
| Serotonin2 receptor-mediated excitation of interneurons in piriform cortex: antagonism by atypical antipsychotic drugs | Q48186971 | ||
| Increases in strychnine-insensitive glycine binding sites in cerebral cortex of chronic schizophrenics: evidence for glutamate hypothesis | Q48189782 | ||
| Activity-dependent changes in GAD and preprotachykinin mRNAs in visual cortex of adult monkeys | Q48202066 | ||
| The distribution of tyrosine hydroxylase-immunoreactive fibers in primate neocortex is widespread but regionally specific. | Q48258530 | ||
| Reduction in number of immunostained GABAergic neurones in deprived-eye dominance columns of monkey area 17. | Q48353707 | ||
| Localization of multiple dopamine receptor subtype mRNAs in human and monkey motor cortex and striatum | Q48428539 | ||
| A candidate molecule approach to defining developmental pathology in schizophrenia | Q48456952 | ||
| Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins | Q48459684 | ||
| Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage | Q48465361 | ||
| D1 and D2 receptor modulation in rat striatum and nucleus accumbens after subchronic and chronic haloperidol treatment | Q48508861 | ||
| Widespread cerebral gray matter volume deficits in schizophrenia | Q48515822 | ||
| Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics | Q48521493 | ||
| Regional cerebral blood flow in schizophrenic disorders | Q48552634 | ||
| A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia | Q48572580 | ||
| Differential expression of synaptophysin and synaptoporin mRNAs in the postnatal rat central nervous system | Q48626749 | ||
| Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons | Q48631451 | ||
| P433 | issue | 1 | |
| P921 | main subject | schizophrenia | Q41112 |
| neurochemistry | Q786278 | ||
| P304 | page(s) | 57-75 | |
| P577 | publication date | 1998-03-01 | |
| P1433 | published in | Psychiatric Clinics of North America | Q7256223 |
| P1476 | title | The neuroanatomy and neurochemistry of schizophrenia | |
| P478 | volume | 21 |
| Q46581750 | Clozapine decreases [3H] CP 55940 binding to the cannabinoid 1 receptor in the rat nucleus accumbens. |
| Q48166781 | Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia |
| Q34424435 | Increased Interstitial White Matter Neuron Density in the Dorsolateral Prefrontal Cortex of People with Schizophrenia |
| Q33946539 | Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: II. Glutamate (Ant)agonists |
| Q35712176 | Postmortem investigations of the pathophysiology of schizophrenia: the role of susceptibility genes |
| Q44507092 | Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia |
| Q30467731 | Sensorimotor gating deficits in transgenic mice expressing a constitutively active form of Gs alpha |
| Q36823176 | Toward a model of memory enhancement in schizophrenia: glucose administration and hippocampal function |
Search more.